SE8702941D0 - PHARMACEUTICAL, N-ACETYL-CYSTEIN-CONTAINING, WATER-SOLUBLE COMPOSITION - Google Patents

PHARMACEUTICAL, N-ACETYL-CYSTEIN-CONTAINING, WATER-SOLUBLE COMPOSITION

Info

Publication number
SE8702941D0
SE8702941D0 SE8702941A SE8702941A SE8702941D0 SE 8702941 D0 SE8702941 D0 SE 8702941D0 SE 8702941 A SE8702941 A SE 8702941A SE 8702941 A SE8702941 A SE 8702941A SE 8702941 D0 SE8702941 D0 SE 8702941D0
Authority
SE
Sweden
Prior art keywords
water
pharmaceutical
cystein
acetyl
weight
Prior art date
Application number
SE8702941A
Other languages
Swedish (sv)
Other versions
SE8702941L (en
SE500493C2 (en
Inventor
A Gazzaniga
V Gianesello
F Stroppolo
Original Assignee
Inpharzam Int Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharzam Int Sa filed Critical Inpharzam Int Sa
Publication of SE8702941D0 publication Critical patent/SE8702941D0/en
Publication of SE8702941L publication Critical patent/SE8702941L/en
Publication of SE500493C2 publication Critical patent/SE500493C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pharmaceutical composition in the form of water-soluble granules comprises: N-Acetylcysteine 10-20% by weight Aspartame 2 - 3% by weight Sorbitol 67-78% by weight Flavouring Agent About 10% by weight The composition has mucolytic activity, is non-cariogenic, and suitable for diabetics. <IMAGE>
SE8702941A 1986-07-24 1987-07-23 Pharmaceutical, water-soluble composition containing N-acetyl-cysteine, aspartame and sorbitol SE500493C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2974/86A CH666814A5 (en) 1986-07-24 1986-07-24 WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN.

Publications (3)

Publication Number Publication Date
SE8702941D0 true SE8702941D0 (en) 1987-07-23
SE8702941L SE8702941L (en) 1988-01-25
SE500493C2 SE500493C2 (en) 1994-07-04

Family

ID=4245819

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702941A SE500493C2 (en) 1986-07-24 1987-07-23 Pharmaceutical, water-soluble composition containing N-acetyl-cysteine, aspartame and sorbitol

Country Status (8)

Country Link
BE (1) BE1000168A3 (en)
CH (1) CH666814A5 (en)
DE (1) DE3723734A1 (en)
FR (1) FR2601875B1 (en)
GB (1) GB2192789B (en)
IT (1) IT1222103B (en)
NL (1) NL194154C (en)
SE (1) SE500493C2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217445B (en) * 1988-04-29 1990-03-22 Altergon Sa SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING ACETYLCISTEIN
CH674940A5 (en) * 1988-05-05 1990-08-15 Ibsa Inst Biochimique Sa
DE3909049A1 (en) * 1989-03-18 1990-09-20 Arthur Boskamp PREPARATION AND THEIR USE
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
IT1256616B (en) * 1992-12-02 1995-12-12 Zambon Spa SYRUP CONTAINING N-ACETYL-CISTEIN
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
DE4406261C2 (en) * 1993-08-31 1996-07-04 Deutsches Krebsforsch Use of thiol compounds to reduce body fat
DE4329857C2 (en) * 1993-09-03 1995-08-24 Deutsches Krebsforsch Connection to strengthen the immune system and immune reactions
BE1007926A3 (en) * 1994-01-31 1995-11-21 Zambon Int Pharma Pharmaceutical composition containing n-acetyl-cysteine.
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
EP1115389B1 (en) 1998-09-25 2014-03-12 PhilERA New Zealand Limited Fructosamine oxidase: antagonists and inhibitors
CN1320160A (en) 1998-09-25 2001-10-31 格利科克斯有限公司 Fructosamine oxidase assay method and materials
EP1293251A1 (en) * 2001-09-14 2003-03-19 Holland Sweetener Company V.o.F. Process for the production of alpha-L-aspartyl-l-phenylalanine methyl ester powder
WO2003077901A1 (en) 2002-03-08 2003-09-25 Protemix Corporation Limited Preventing and/or treating cardiovascular disease and/or associated heart failure
US20060100278A1 (en) 2002-08-20 2006-05-11 Cooper Garth J S Dosage forms and related therapies
ES2449066T3 (en) 2004-07-19 2014-03-18 Philera New Zealand Limited Synthesis of triethylenetetramines
GR1007236B (en) * 2009-12-07 2011-04-08 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, New pharmaceutical composition of n-acetylcysteine granules and production method thereof
IT1399492B1 (en) * 2010-04-13 2013-04-19 Alpex Pharma Sa EFFERVESCENT PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCISTEIN.
CN103142505B (en) * 2013-03-29 2015-03-11 山东罗欣药业集团股份有限公司 Acetylcysteine composition granules and preparation method thereof
EP3505153B1 (en) 2017-12-31 2021-03-24 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. A pharmaceutical composition comprising acetylcysteine which is free of methylparaben and propylparaben
CN113559078A (en) * 2021-07-02 2021-10-29 安徽省先锋制药有限公司 Preparation method of acetylcysteine effervescent tablets

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617638A1 (en) * 1967-05-24 1971-05-13 Miles Lab Tablet binder
CH646843A5 (en) * 1982-02-17 1984-12-28 Xyrofin Ag Sugar substitute, method for its production, and its use
DE3317558A1 (en) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Oral antisnoring composition
DE3317530A1 (en) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antisnoring composition
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
IT1170268B (en) * 1983-12-21 1987-06-03 Zambon Spa USE OF ACETYLCISTEIN TO REDUCE THE INCREASE IN THE PROLIEFERATION OF THE BASAL CELLS OF THE RESPIRATORY THRACHEO-BRONCHIAL EPITHELIUM INDUCED BY TOBACCO SMOKE IN MAMMALS
DE3514995A1 (en) * 1985-04-25 1986-10-30 Protopharma Ltd., 7831 Malterdingen Use of sulfhydryl pharmaceuticals for combating damage to the gastric mucosa

Also Published As

Publication number Publication date
FR2601875B1 (en) 1992-02-21
GB8717581D0 (en) 1987-09-03
SE8702941L (en) 1988-01-25
CH666814A5 (en) 1988-08-31
NL194154C (en) 2001-08-03
GB2192789A (en) 1988-01-27
BE1000168A3 (en) 1988-07-05
NL8701744A (en) 1988-02-16
NL194154B (en) 2001-04-02
FR2601875A1 (en) 1988-01-29
DE3723734C2 (en) 1992-05-21
SE500493C2 (en) 1994-07-04
DE3723734A1 (en) 1988-02-04
IT8721410A0 (en) 1987-07-23
IT1222103B (en) 1990-08-31
GB2192789B (en) 1990-01-31

Similar Documents

Publication Publication Date Title
SE8702941L (en) PHARMACEUTICAL, N-ACETYL-CYSTEIN-CONTAINING, WATER-SOLUBLE COMPOSITION
SE8702940D0 (en) PHARMACEUTICAL, N-ACETYL-CYSTEIN-CONTAINING, WATER-SOLUBLE COMPOSITION
IT8520998A0 (en) GRANULE CONTAINING PHYSIOLOGICALLY ACTIVE SUBSTANCE, METHOD FOR ITS PREPARATION AND ITS USE.
IT8548373A0 (en) PROPOSED AMINO DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES
SE8901671L (en) LAEKEMEDELSADSORBAT
IT8847556A0 (en) PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINES
PT92271A (en) PROCESS FOR OBTAINING EFFERVESCENT PREPARATIONS OF IBUPPHENE
IT1217445B (en) SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING ACETYLCISTEIN
IL51643A0 (en) Novel 4,5-dichloroimidazole-2-carboxylic acid derivatives their preparation and their use as pesticides
MX9101009A (en) PHARMACEUTICAL COMPOSITION CONTAINING FURAN DERIVATIVES AND PROCEDURE FOR ITS PREPARATION
ES2060163T3 (en) PHARMACEUTICAL COMPOSITION BASED ON PARACETAMOL.
DE68900152D1 (en) ACIDYLCYSTONE-CONTAINING SOLID, WATER-SOLUBLE MEDICINAL PRODUCT.
GB2021409A (en) Pharmaceutical composition
DE69017969T2 (en) Fragrance composition containing 2-cyclohexylpropionic acid or derivatives thereof.
FI821324A0 (en) OXAZOLDERIVAT
IT8026233A0 (en) DERIVATIVE OF N-ACETYL-CYSTEINE WITH THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
EG14021A (en) Fungicidally an nematocidally active 1,3,4-thiadiozole-2-carboxylic acid derivatives and their manufacture and use
DK179786D0 (en) (-) - 1BETA-ETHYL-1ALFA-HYDROXYLMETHYL-1,2,3,4,6,7,12,12BALFA-OCTA-HYDROINDOLO (2,3-A) QUINOLIZIN AND ACID ADDITION SALTS THEREOF, THEIR PREPARATION AND USE AS PHARMACEUTICAL
IT7824637A0 (en) SODIUM SALT OF MERCAPTOPIONYLGLYCINE, PROCESS FOR ITS PREPARATION AND ITS THERAPEUTIC USES.
IT8249771A0 (en) CYCLOHEXANONE DERIVATIVES HAVING HERBICANT ACTIVITY, AND PROCEDURE FOR THEIR PREPARATION
IE782515L (en) Treating diarrhoea
JPS53149940A (en) Novel benzyl alcohol derivatives and their preparation
JPS52120132A (en) Remedies for nephric diseases
IT1156162B (en) ORAL ANTI-TUMORAL COMPOSITION AND PROCEDURE TO PROMOTE ITS ABSORPTION BY THE INTESTINE
JPS53127432A (en) Novel physiologically active substance, anthglutin, and its preparation

Legal Events

Date Code Title Description
NUG Patent has lapsed